Synonyms: RP-54476 | RP54476 | Synercid® (dalfopristin + quinupristin)
dalfopristin is an approved drug (FDA (1999))
Compound class:
Synthetic organic
Comment: Dalfopristin is a semi-synthetic derivative of pristinamycin IIA (streptogramin A). It inhibits the early phase of protein synthesis in the bacterial ribosome by binding to the 70S subunit. It is administered intravenously.
|
|
No information available. |
Summary of Clinical Use ![]() |
Dalfopristin is intravenously administered in fixed combination with quinupristin to treat severe bacterial infections due to susceptible organisms including methicillin resistant Staphylococcus aureus (MRSA) or Streptococcus pyogenes. |
External links ![]() |
For extended ADME data see the following: Drugs.com |